BOSTON, May 26 /PRNewswire/ -- Thomson CompuMark, a Thomson Reuters business, today announced new, proprietary FDA drug sources in its Pharmaceutical XC Search, plus authentic FDA Phonetic Orthographic Computer Analyses (POCAs) of potential marks, both of which reduce the risk of pharmaceutical brand conflicts. This new content comprises the world's most comprehensive coverage of drug-related brands and helps companies protect their investment in creating, clearing and registering drug trademarks.
"With so many drug names on the market, pharmaceutical brand owners face particularly complex challenges when developing new trademarks," said Martin Burke, group managing director of Thomson CompuMark. "Expanding the coverage of our industry-leading Pharmaceutical XC Search is just the latest example of how Thomson Reuters keeps brand owners, and the IP professionals who advise them, ahead of the curve, providing the most complete information to help them make better decisions and reduce their business risk."
Pharmaceutical XC Search offers:
For more information on Pharmaceutical XC Search, go to http://compumark.thomson.com/do/pharmaceutical.
About Thomson CompuMark
Thomson CompuMark, a part of Thomson Reuters, delivers comprehensive solutions for global trademark research and brand protection, powered by the most extensive trademark resources in the world. Widely recognized as the global industry leader, Thomson CompuMark currently serves 80 of the top 100 brand owners and many of the world's leading intellectual property law firms.
About Thomson Reuters
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs 55,000 people and operates in over 100 countries. For more information, go to www.thomsonreuters.com.
|SOURCE Thomson CompuMark|
Copyright©2010 PR Newswire.
All rights reserved